Fundraising FoxDivergent Capital — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Ceragen is a Canadian biotechnology company providing DNA and viral sequencing services to greenhouse and field growers to monitor crop health and manage plant disease.
AgTechBiotechKitchener, CA
Matthew Rose(Co-Founder and CEO)inJeffrey Mores(Executive Officer)Danielle Rose(Executive Officer, Director)
Co-investorsSOSV
Hoop builds AI agents that help individuals and teams manage context, prioritize what matters, and follow through on work spread across email, chat, meetings, and documents.
AI & Machine LearningE-commerceFuture of WorkSaaSNew York City, US
Brian Schmidt(Co-founder, Operations, Finance & Legal)inJustin Gallagher(Co-founder, Product, Engineering & Design)inStella Garber(Co-founder, Go to Market)in
Co-investorsIndex VenturesOrigin VenturesChingona VenturesustwoVenture Guides Management, L.P.Y Combinator
Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.
BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US
Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)inKaiyuan Yang(Founder)
Co-investorsArboretum VenturesDolby Family VenturesFeatures Capital HoldingsPsyMed VenturesTMC Venture FundXEIA Venture Partners+6 more
Paterna Biosciences is developing a first-in-class biologic for reproductive biology using in vitro spermatogenesis technology.
BiotechDigital HealthFemTechHealthtechMedical DevicesSalt Lake City, US
Alex Pastuszak(Co-founder and Chief Executive Officer)Brad Cairns(Co-founder and Chief of Scientific Advisors)Jim Hotaling(Co-founder and Chairman)Danny Mitchell(Executive Officer)Edward Rowland(Executive Officer)Ryan Morley(Director)
Co-investorsDraper AssociatesSeaside VenturesSpringTide VenturesUtah Innovation Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.